Doctor profile · Federal record

Dr. Laila Hassan, M.D. P.A.

Rheumatology Physician (CMS: Rheumatology) · Preferred Provider Organization · Houston, TX

  • NPI 1942395496
  • Accepts Medicare
  • MIPS 98.0 / 100 · 2023
  • 41 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
11914 Astoria Blvd. #330
Houston, TX 77089
(281) 922-4000
fax (281) 922-4242

Credentials & registration

NPPES · NUCC
NPI registered
October 2006 — 20 yrs on file
Profile last updated
December 10, 2013
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Texas #J3009
Medicaid
TX #123653101

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1942395496. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
161,562
Distinct HCPCS
10
Medicare allowed
$2,467,712
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 61,600 20 $5
J1602 Injection, golimumab, 1 mg, for intravenous use 48,690 54 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 17,375 28 $41
J3111 Injection, romosozumab-aqqg, 1 mg 13,860 13 $9
J0897 Injection, denosumab, 1 mg 10,560 107 $23
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg 3,104 76 $17
J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg 2,400 42 $17
99214 Established patient office or other outpatient visit, 30-39 minutes 940 374 $131
96413 Administration of chemotherapy into vein, 1 hour or less 597 91 $134
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 433 91 $1

In context: peer comparison

Among 35 peers in this city , average services per provider: 2,499. This provider delivers 65× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,945
Transactions
66
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 12 $352.89
AstraZeneca Pharmaceuticals LP 13 $299.92
ABBVIE INC. 13 $273.02
UCB, Inc. 4 $121.09
Novartis Pharmaceuticals Corporation 2 $92.44
Novo Nordisk Inc 4 $85.17
Xeris Pharmaceuticals, Inc. 1 $80.24
Lilly USA, LLC 2 $57.22
Janssen Biotech, Inc. 2 $51.07
Corcept Therapeutics 2 $46.39
BETA BIONICS, INC. 3 $45.51
GlaxoSmithKline, LLC. 2 $42.38
Bayer Healthcare Pharmaceuticals Inc. 2 $42.37
Dexcom, Inc. 2 $42.11
Esperion Therapeutics, Inc. 2 $39.13

By nature of payment

Food and Beverage
$1,945

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,015
Patients
1,143
Total drug cost
$97,637
Drug Type Claims Patients Total cost
Celecoxib Generic 646 250 $31,269
Methotrexate (Methotrexate Sodium) Brand 389 133 $15,697
Prednisone Generic 380 160 $5,217
Alendronate Sodium Generic 339 116 $4,036
Duloxetine Hcl Generic 301 96 $7,408
Hydroxychloroquine Sulfate Generic 256 81 $18,582
Gabapentin Generic 123 53 $2,035
Folic Acid Generic 105 33 $491
Methylprednisolone Generic 87 45 $2,704
Methocarbamol Generic 85 41 $1,504

Frequently asked questions

Auto-generated from federal data
What is Dr. Laila Hassan's medical specialty?
Dr. Laila Hassan practices Rheumatology Physician in Houston, TX.
Where does Dr. Laila Hassan practice?
Dr. Laila Hassan practices at 11914 Astoria Blvd. #330, Houston, TX 77089. Office phone: 2819224000.
What is Dr. Laila Hassan's NPI?
Dr. Laila Hassan's National Provider Identifier (NPI) is 1942395496, issued by NPPES.
Does Dr. Laila Hassan accept Medicare assignment?
Yes. Dr. Laila Hassan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Laila Hassan commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.